Colorectal metastases is facilitated by specific alterations in tumor cell surface molecules involved in cellular recognition and adhesion. Genetic changes (loss of DCC, deleted in colorectal cancer, gene) leading to the deletion of neural cell adhesion-like molecule (NCAM) have been observed in colorectal cancer progression. Furthermore, overexpression of other colorectal carcinoma glycoproteins (e.g. CEA) implicated in adhesive interactions has been found to be associated with increased metastatic potential. Together these findings raise considerable interest in colorectal tumor cell surface glycoproteins and glycolipids, an the role these molecules play in tumor cell adhesion, recognition, growth and invasion. To target CEA and other colon tumor cell surface glycoconjugates, 3- and 4-fluorinated derivatives of glucosamine (e.g. 4-F- GlcNAc) were synthesized by our group as potential oligosaccharide chain terminators and/or modifiers. By substitution of fluorine into the C3 or C4 position, these analogs were designed to block the biosynthesis of Galpha1beta1 yields 4 GlcNAc and Fuc alpha1 yields 3 GlcNac oligosaccharide linkages, important constituents of polylactosaminoglycans and various antigenic blood groupings, including sialylated lewis X.
The aim of this proposal is to evaluate the biochemical, biological and preclinical therapeutic activities of these fluoro-sugars, and several other newly synthesized monosaccharide analogs and oligosaccharides, using various human colon carcinoma cell lines and tumor models. Preliminary studies have indicated that treatment of HT-29 human colon carcinoma cells with a 4-F-GlcNAc analog resulted in decreased expression of certain cell surface glycoconjugates (e.g. CEA) correlating with decreased homotypic aggregation. Additionally, following exposure of these cells to this sugar analog, reductions in HT-29 cell surface sialylated Lewis X reactivity were noted with corresponding decreases in adhesion to IL-1beta stimulated endothelial cells (an E-selectin mediated adhesion system). Such losses in surface glycoconjugate expression and cell-to-cell adhesiveness may result in an inability for such tumor cells to metastasize. Using magnetic resonance imaging (MRI), we propose to monitor the advent of liver metastases (from intrasplenic and/or orthotopic tumor implants) in nude athymic (or SCID) mice, and to assess the preclinical therapeutic efficacy of anti-adhesive therapies. it is anticipated that these studies will increase our knowledge concerning mechanisms of colon tumor cell adhesion, invasion, growth regulation and metastases, perhaps leading to the discovery and development of new and unique agents having antitumor and/or antimetastatic activity.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA070853-03
Application #
2700677
Study Section
Experimental Therapeutics Subcommittee 1 (ET)
Program Officer
Wolpert, Mary K
Project Start
1996-05-01
Project End
2000-04-30
Budget Start
1998-05-01
Budget End
2000-04-30
Support Year
3
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Roswell Park Cancer Institute Corp
Department
Type
DUNS #
City
Buffalo
State
NY
Country
United States
Zip Code
14263
Marasco Jr, Canio J; Pera, Paula J; Spiess, Arthur J et al. (2005) Improved synthesis of beta-D-6-methylpurine riboside and antitumor effects of the beta-D- and alpha-D-anomers. Molecules 10:1015-20
Dimitroff, C J; Klohs, W; Sharma, A et al. (1999) Anti-angiogenic activity of selected receptor tyrosine kinase inhibitors, PD166285 and PD173074: implications for combination treatment with photodynamic therapy. Invest New Drugs 17:121-35
Dimitroff, C J; Pera, P; Dall'Olio, F et al. (1999) Cell surface n-acetylneuraminic acid alpha2,3-galactoside-dependent intercellular adhesion of human colon cancer cells. Biochem Biophys Res Commun 256:631-6
Dimitroff, C J; Sharma, A; Bernacki, R J (1998) Cancer metastasis: a search for therapeutic inhibition. Cancer Invest 16:279-90
Sharma, A; Glaves, D; Porter, C W et al. (1997) Antitumor efficacy of N1,N11-diethylnorspermine on a human bladder tumor xenograft in nude athymic mice. Clin Cancer Res 3:1239-44
Sharma, A; Bernacki, R J (1997) Ovarian cancer patients with high CA-125 but no symptoms--should antiangiogenic treatments be considered? Oncol Res 9:53-4
Sharma, A; Mayhew, E; Bolcsak, L et al. (1997) Activity of paclitaxel liposome formulations against human ovarian tumor xenografts. Int J Cancer 71:103-7
Woynarowska, B; Dimitroff, C J; Sharma, M et al. (1996) Inhibition of human HT-29 colon carcinoma cell adhesion by a 4-fluoro-glucosamine analogue. Glycoconj J 13:663-74